- Home
- XOMA vs MGTX Comparison
XOMA vs MGTX Comparison
Compare XOMA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- MGTX
- Stock Information
- Founded
- XOMA 1981
- MGTX 2015
- Country
- XOMA United States
- MGTX United States
- Employees
- XOMA N/A
- MGTX N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XOMA Health Care
- MGTX Health Care
- Exchange
- XOMA Nasdaq
- MGTX Nasdaq
- Market Cap
- XOMA 330.2M
- MGTX 622.0M
- IPO Year
- XOMA N/A
- MGTX N/A
- Fundamental
- Price
- XOMA $26.26
- MGTX $8.68
- Analyst Decision
- XOMA Strong Buy
- MGTX Strong Buy
- Analyst Count
- XOMA 2
- MGTX 2
- Target Price
- XOMA $69.50
- MGTX $24.00
- AVG Volume (30 Days)
- XOMA 88.0K
- MGTX 538.8K
- Earning Date
- XOMA 08-12-2025
- MGTX 08-11-2025
- Dividend Yield
- XOMA N/A
- MGTX N/A
- EPS Growth
- XOMA N/A
- MGTX N/A
- EPS
- XOMA N/A
- MGTX N/A
- Revenue
- XOMA $42,909,000.00
- MGTX $34,508,000.00
- Revenue This Year
- XOMA $70.91
- MGTX $365.04
- Revenue Next Year
- XOMA $14.00
- MGTX $73.18
- P/E Ratio
- XOMA N/A
- MGTX N/A
- Revenue Growth
- XOMA 638.41
- MGTX 203.23
- 52 Week Low
- XOMA $18.35
- MGTX $3.85
- 52 Week High
- XOMA $35.00
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- XOMA 50.27
- MGTX 79.48
- Support Level
- XOMA $27.08
- MGTX $6.31
- Resistance Level
- XOMA $28.70
- MGTX $8.75
- Average True Range (ATR)
- XOMA 1.24
- MGTX 0.43
- MACD
- XOMA 0.00
- MGTX 0.19
- Stochastic Oscillator
- XOMA 36.29
- MGTX 96.90
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.